Antihyperglycemic Effect on Chronic Administration of Butanol Fraction of Ethanol Extract of Moringa Stenopetala Leaves in Alloxan Induced Diabetic Mice

Asian Pacific Journal of Tropical Biomedicine

Volumn 2, Issue 3 SUPPL., 2012, Pages

  Toma, Alemayehu ^a   Makonnen, Eyasu ^b   Debella, Asfaw ^c   Tesfaye, Birhanu ^c  

^a HAWASSA UNIVERSITY   (Ethiopia)

^b ADDIS ABABA UNIVERSITY   (Ethiopia)

^c ETHIOPIAN PUBLIC HEALTH INSTITUTE   (Ethiopia)

Author keywords

Alloxan induced diabetic mice; Antihyperglycemic effect; Butanol fraction; LD50; Moringa stenopetala

Indexed keywords

ALCOHOL; ANTIDIABETIC AGENT; BUTANOL; CHOLESTEROL; GLIBENCLAMIDE; GLUCOSE; MORINGA STENOPETALA EXTRACT; PLANT EXTRACT; THIAMPHENICOL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; LD 50; LONG TERM EXPOSURE; MALE; MORINGA; MORINGA STENOPETALA; MOUSE; NONHUMAN; PLANT LEAF; PRIORITY JOURNAL; TOXICITY TESTING; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT CHANGE; WEIGHT GAIN;

MORINGA STENOPETALA; MUS;

EID: 84875389287     PISSN: 22211691     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2221-1691(12)60461-4     Document Type: Article

References (14)

1. Altan V The pharmacology of diabetic complications. Current Medicinal Chemistry 2003, 10:1317-1327.
2. Upendra M, Sreenivasulu M, Chengaiah B Micro vascular and macro vascular complication of diabetes mellitus. IJPRIF 2010, 2:1883-1892. (2010).
3. Strojek K Features of macrovascular complications in type 2 diabetic patients. Acta Diabetologica 2003, 40:334-337. (2003).
4. Mussa A, Makonnen E, Urga K Effect of the crude aqueous extract and isolated fraction of Moringa stenopetala leaves in normal diabetic mice. Pharmacology online 2008, 3:1049-1055.
5. World Health Organization OECD guideline for testing of chemicals -Acute Oral Toxicity - Acute Toxic Class Method 2008, pp: 1-14.
6. Lenzen S, Tiedge M, Jorns A, Munday R Alloxan derivatives as a tool for the elucidation of the mechanism of the diabetogenic action of alloxan. Lessons from Animal Diabetes 2010, 113-122. Birkhauser, Boston. E. Shafrir (Ed.).
7. Mythili M, Vyas R, Akila G, Gunasekaran S Effect of streptozotocin on the ultrastructure of rat pancreatic islets. Microscopy Research and Technique 2009, 63:274-281.
8. Nardos A, Makonnen Y, Debella A Hypoglycemic and antihyperglycemic activities of Ethanol extract and fractions of moringa stenopetala leaves in normoglycemic and alloxan induced diabetic mice. African Journal of Pharmacy and Pharmacology 2011, 20:2220-2225.
9. Tiwari A, Rao M Diabetes mellitus and multiple therapeutic approaches of phytochemicals: present status and future prospects. Curr. Sci 2002, 83:30-38.
10. Mukherjee P, Maiti K, Mukherjee K, Houghton P Leads from Indian medicinal plants with hypoglycemic potentials. J Ethnopharmacol 2006, 106:1-28.
11. Rao A, Gurfinkel D The bioactivity of saponins: triterpenoid and steroidal glycosides. Drug Metab Drug Interact 2000, 17:211-235.
12. Mekonnen N, Houghto P, Timbrell J Toxicity of Extracts of Plant Parts of Moringa stenopetala in HEPG2 Cells in Vitro. Phytother. Res 2005, 19:870-875.
13. Abuye C, Urga K, Knapp H, Selmar D, Omwega A, Imungi J, Winterhalter P A compositional study of Moringa stenopetala leaves. East Afr Med J 2003, 80:247-252.
14. Friode T, Medeiros Y Animal models to test drugs with potential antidiabetic activity. Journal of Ethnopharmacology 2008, 115:173-183.